Core Viewpoint - Beijing Stock Exchange (BSE) has approved Shenzhen Peicheng Technology Co., Ltd. for IPO, despite concerns regarding its financial performance and the rationale behind its fundraising plans [1][2]. Group 1: Company Performance - Peicheng Technology's revenue has been declining, with figures of 850 million yuan in 2022, 764 million yuan in 2023, and projected 733 million yuan in 2024, marking a cumulative decline of 13.8% over three years [2]. - The net profit for the same period shows fluctuations, with a decrease in 2024's non-recurring net profit by 20.13% [2]. - The company reported a cash dividend of 65.5 million yuan in 2022 and 12 million yuan in 2023, totaling 77.5 million yuan over two years [3]. Group 2: Fundraising and Financial Health - Peicheng Technology plans to raise 500 million yuan, with allocations of 294 million yuan for production capacity enhancement, 144 million yuan for R&D center construction, and 62 million yuan for working capital [2]. - Despite having a strong liquidity position with 280 million yuan in cash and no short-term debt as of June, the rationale for raising funds for working capital is questioned [3]. Group 3: IPO Review Process - The BSE has expedited its IPO review process, particularly towards the end of the year, influenced by financial report updates and a surge in IPO applications [4]. - The average time from acceptance to listing on the BSE is 339 days, making it an attractive option for companies initially targeting larger exchanges [4]. - The BSE maintains strict scrutiny over income recognition and performance stability, as evidenced by the recent deferral of two companies' IPO reviews due to compliance issues [5].

Core Viewpoint - The Beijing Stock Exchange (BSE) is accelerating its IPO review process, with a focus on the sustainability and authenticity of company performance, as well as the necessity of fundraising projects [1][2]. Group 1: IPO Review Process - The BSE's listing committee held its 46th to 49th review meetings from December 22 to 26, 2025, approving four companies: Ying's Holdings, Longyuan Co., Puan Medical Technology, and New Hengtai New Materials, all meeting the issuance and listing requirements [1]. - Key concerns during the review included the sustainability of performance growth, accuracy of revenue recognition, reasons for declining gross margins, and the authenticity of online sales revenue [1]. Group 2: Company Performance - Ying's Holdings reported revenues of 1.296 billion yuan, 1.758 billion yuan, 1.974 billion yuan, and 1.132 billion yuan from 2022 to the first half of 2025, with net profits of 114 million yuan, 216 million yuan, 190 million yuan, and 136 million yuan [2]. - Longyuan Co. achieved revenues of 519 million yuan, 699 million yuan, 869 million yuan, and 475 million yuan during the same period, with net profits of 97 million yuan, 118 million yuan, 112 million yuan, and 61 million yuan [2]. - New Hengtai and Puan Medical also showed optimistic performance, with New Hengtai's revenues reaching 530 million yuan, 679 million yuan, 774 million yuan, and 384 million yuan, and net profits of 45 million yuan, 101 million yuan, 91.76 million yuan, and 51.35 million yuan [2]. Group 3: Quality of Companies in the Pipeline - As of December 25, 2025, there are 168 companies in the BSE's IPO queue, with only one company projected to be unprofitable in 2024, indicating an overall improvement in the quality of companies seeking to go public [4]. - Among the 168 companies, 50 have net profits exceeding 100 million yuan, accounting for 29.8% of the total [4]. - New companies entering the IPO process, such as Hubei Benxing New Materials, reported revenues of 3.726 billion yuan, 3.606 billion yuan, 4.445 billion yuan, and 2.287 billion yuan from 2022 to the first half of 2025, with net profits of 451 million yuan, 356 million yuan, 389 million yuan, and 199 million yuan [4].

Core Viewpoint - The successful IPO of Dapeng Industrial marks the first instance of a company with a net profit below 40 million yuan passing the review under the new "National Nine Articles," raising questions about the current IPO review logic of the Beijing Stock Exchange [1][5][10] Group 1: IPO Review and Company Performance - Dapeng Industrial is the only company among the 35 that passed the IPO review with a net profit of 38.1 million yuan, below the 40 million yuan threshold [3][5] - The company has experienced a complex IPO process, including multiple changes in audit firms and a history of application rejections, which have impacted its financial performance [6][7] - The company reported revenues of 247 million yuan, 260 million yuan, and 265 million yuan from 2022 to 2024, showing continuous growth, but net profits fluctuated, with a decline in 2024 [7][9] Group 2: Financial Metrics and Government Support - Dapeng Industrial's net profit attributable to the parent company decreased from 40.3 million yuan in 2023 to 38.1 million yuan in 2024, influenced by reduced government subsidies [8][9] - Government subsidies accounted for 16.41%, 28.16%, and 28.86% of total profits from 2022 to 2024, indicating some reliance on these funds, although the company claims not to be significantly dependent on them [9][10] Group 3: Customer Dynamics and Revenue Sources - The company’s top five customers accounted for 84.20%, 55.27%, and 75.44% of sales from 2022 to 2024, with significant revenue decline from its largest customer, BYD, due to changes in procurement policies [9][10] - Dapeng Industrial's overseas revenue dropped to zero starting in 2023, leading to a strategic decision to dispose of its Japanese subsidiary [10]